Vitrolife ABOSTO:VITR -0.89%79 Median PS Value is kr324.07 as of Jun. 30, 2026, which is 100% below its 10-year median of 0.76. GuruFocus rates OSTO:VITR with a GF Score™ of 79/100 and a GF Value™ of kr162.15 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 335 Medical Devices & Instruments companies, Vitrolife AB ranks better than 90.15% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Vitrolife AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr25.136. Vitrolife AB's 10-Year median PS Ratio is 12.8927. Therefore, the Median PS Value for today is kr324.07.
As of today (2026-06-30), Vitrolife AB's share price is kr88.85. Vitrolife AB's Median PS Value is kr324.07. Therefore, Vitrolife AB's Price to Median PS Value for today is 0.27.
The historical rank and industry rank for Vitrolife AB's Median PS Value or its related term are showing as below:
OSTO:VITR'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.27 Med: 0.76 Max: 3.76
Current: 0.27
During the past 13 years, the highest Price to Median PS Value of Vitrolife AB was 3.76. The lowest was 0.27. And the median was 0.76.
OSTO:VITR's Price-to-Median-PS-Value is ranked better than 90.15% of 335
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs OSTO:VITR: 0.27
Vitrolife AB (OSTO:VITR) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Vitrolife AB's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
88.85
/
324.07
=
0.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitrolife AB Median PS Value Related Terms
Vitrolife AB Median PS Value Historical Data
* Premium members only.
The historical data trend for Vitrolife AB's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:VITR vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Vitrolife AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitrolife AB Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Vitrolife AB's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 12.8927.
Vitrolife AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr25.136.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vitrolife AB (OSTO:VITR) has a Median PS Value of kr324.07 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vitrolife AB and its competitors. This is 42541% above median its historical median of 0.76. Over the past decade, Vitrolife AB's Median PS Value has ranged from 0.27 to 3.76. According to the industry distribution chart, Vitrolife AB ranks #33 out of 335 companies in the Medical Devices & Instruments industry, placing it in the top 9.9%.
Is Vitrolife AB's Median PS Value too high?
Vitrolife AB's current Median PS Value of kr324.07 is 42541% above median its 10-year median of 0.76. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 3.76. Based on the distribution chart, Vitrolife AB ranks #33 out of 335 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vitrolife AB has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vitrolife AB's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vitrolife AB ranks #33 out of 335 companies for Median PS Value. This places Vitrolife AB in the top 10% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, Vitrolife AB's own Median PS Value has ranged from 0.27 to 3.76 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 335 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Vitrolife AB and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitrolife AB's current Median PS Value is kr324.07, which is 42541% above median its own 10-year median of 0.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitrolife AB stock overvalued right now?
Based on GuruFocus' analysis, Vitrolife AB (OSTO:VITR) is currently considered Possible Value Trap. The stock's GF Value™ is kr162.15, compared to a current price of kr88.85 — trading 45.2% below its estimated fair value. The current Median PS Value is kr324.07, which is 42541% above median its 10-year median of 0.76. Vitrolife AB's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Vitrolife AB (OSTO:VITR), the current Median PS Value is kr324.07 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vitrolife AB (OSTO:VITR) Overvalued in 2026?
Based on GuruFocus' analysis, Vitrolife AB stock appears to be undervalued.
The current stock price of kr88.85 is trading 45.2% below its estimated GF Value™ of kr162.15.
GuruFocus considers Vitrolife AB to be Possible Value Trap.
Key valuation signals for OSTO:VITR:
Median PS Value: kr324.07 (42541% above median its 10-year median of 0.76)
GF Value™: kr162.15 vs. price of kr88.85 (45.2% below fair value)
No single metric tells the full story. See the OSTO:VITR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The company has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.
79GF Score
Get the complete analysis for OSTO:VITR
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:VITR has been successfully added to your 
